- Home
- LRMR vs PACB Comparison
LRMR vs PACB Comparison
Compare LRMR & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- PACB
- Stock Information
- Founded
- LRMR N/A
- PACB 2000
- Country
- LRMR United States
- PACB United States
- Employees
- LRMR N/A
- PACB N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- LRMR Health Care
- PACB Industrials
- Exchange
- LRMR Nasdaq
- PACB Nasdaq
- Market Cap
- LRMR 426.9M
- PACB 364.2M
- IPO Year
- LRMR N/A
- PACB 2010
- Fundamental
- Price
- LRMR $3.19
- PACB $1.54
- Analyst Decision
- LRMR Strong Buy
- PACB Buy
- Analyst Count
- LRMR 9
- PACB 13
- Target Price
- LRMR $19.44
- PACB $2.79
- AVG Volume (30 Days)
- LRMR 639.4K
- PACB 14.1M
- Earning Date
- LRMR 03-13-2025
- PACB 02-13-2025
- Dividend Yield
- LRMR N/A
- PACB N/A
- EPS Growth
- LRMR N/A
- PACB N/A
- EPS
- LRMR N/A
- PACB N/A
- Revenue
- LRMR N/A
- PACB $154,014,000.00
- Revenue This Year
- LRMR N/A
- PACB $22.84
- Revenue Next Year
- LRMR N/A
- PACB $30.91
- P/E Ratio
- LRMR N/A
- PACB N/A
- Revenue Growth
- LRMR N/A
- PACB N/A
- 52 Week Low
- LRMR $3.01
- PACB $1.16
- 52 Week High
- LRMR $12.91
- PACB $6.09
- Technical
- Relative Strength Index (RSI)
- LRMR 37.56
- PACB 45.60
- Support Level
- LRMR $3.06
- PACB $1.27
- Resistance Level
- LRMR $3.52
- PACB $2.06
- Average True Range (ATR)
- LRMR 0.22
- PACB 0.21
- MACD
- LRMR 0.02
- PACB 0.03
- Stochastic Oscillator
- LRMR 15.66
- PACB 34.18
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.